在AMPA受体中,有的竞争和抑制作用
W Dylan Hale1,2, Alejandra Montaño Romero1,2, Cuauhtemoc U Gonzalez3,4
1Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD USA.
bioRxiv : the preprint server for biology
|December 11, 2023
概括
负调节剂,如GYKI-52466,通过将谷氨酸结合与通道开放脱而抑制α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic酸受体 (AMPARs). 这个机制为神经系统疾病提供了新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 分子药理学分子药理学
- 结构生物学是结构生物学.
背景情况:
- 刺激性神经传递依赖于AMPA亚型的离子型谷氨酸受体 (AMPARs).
- AMPAR失调与许多神经系统疾病有关.
- 对AMPARs的负基调制剂 (NAM) 的精确抑制机制仍然不完全理解.
研究的目的:
- 阐明负调节剂对AMPARs非竞争性抑制的机制.
- 为了研究AMPARs的负和正调节器之间的全性相互作用.
- 为设计AMPAR向治疗提供结构和机制基础.
主要方法:
- 使用冷电子显微镜捕获AMPAR与谷氨酸和GYKI-52466.6复合体中的AMPAR.
- 进行了结构分析,以确定由调节器诱导的结合部位和构造变化.
- 使用功能性测试来评估调节剂对AMPAR活性的影响.
主要成果:
- 通过GYKI-52466进行非竞争性抑制,使AMPAR变得不敏感,并防止积极的全调节.
- GYKI-52466与跨膜领区域结合,将连接体结合与离子通道关脱.
- 通过GYKI-52466进行负基调制,有效地超越了正基调制剂的竞争力.
结论:
- 建立了一个结构框架,以了解AMPAR全调制.
- 提供了非竞争性AMPAR抑制机制的见解.
- 为合理的药物设计奠定了基础,针对神经疾病的AMPAR.
相关概念视频
Allosteric Regulation
58.0K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
58.0K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Enzyme Inhibition
78.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.4K
Feedback Inhibition
53.9K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
53.9K


